Target intelligence / Profile preview

Lectin, galactoside-binding, soluble, 13 pseudogene (LGALS13 pseudogene)

Target: LGALS13 pseudogene
Molecular classification: Other (Pseudogene)

Overview

Lectin, galactoside-binding, soluble, 13 pseudogene (LGALS13 pseudogene) is a non-coding pseudogene belonging to the galectin family. Pseudogenes are genomic sequences similar to normal genes but are non-functional and typically do not produce proteins. This gene is not considered a therapeutic target and has no known biological activity, clinical relevance, or associated drug interactions[1][2].

Other names: CTB-60E11.12 unprocessed pseudogeneLGALS13 pseudogene

Beyond the preview

Go deeper on Lectin, galactoside-binding, soluble, 13 pseudogene (LGALS13 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lectin, galactoside-binding, soluble, 13 pseudogene (LGALS13 pseudogene).

Explore the full profile